BCAX

Bicara Therapeutics

• TipRanks·1d ago

  Bicara Therapeutics’ Earnings Call Highlights Pivotal Pivot

• TipRanks·1d ago

  JonesTrading Sticks to Its Buy Rating for Bicara Therapeutics Inc. (BCAX)

• Reuters·5d ago

  Bicara Therapeutics grants new employee stock option for 44,175 shares under inducement plan

• Reuters·5d ago

  BICARA THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·6d ago

  Bicara Therapeutics management to meet with Citizens

• Benzinga·6d ago

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• Seeking Alpha·03/31 19:34

  Bicara: Maintaining 'Buy' Rating On Ficerafusp Alfa Phase 3 Advancement

• Dow Jones·03/31 16:44

  Bicara Therapeutics Is Maintained at Neutral by Goldman Sachs

• Benzinga·03/31 16:34

  Goldman Sachs Maintains Neutral on Bicara Therapeutics, Raises Price Target to $16

• Dow Jones·03/31 14:24

  Bicara Therapeutics Price Target Maintained With a $30.00/Share by Wedbush

• TipRanks·03/31 14:16

  Wedbush Sticks to Its Buy Rating for Bicara Therapeutics Inc. (BCAX)

• Dow Jones·03/31 14:03

  Bicara Therapeutics Is Maintained at Equal-Weight by Wells Fargo

• Benzinga·03/31 13:53

  Wells Fargo Maintains Equal-Weight on Bicara Therapeutics, Raises Price Target to $16

• Dow Jones·03/31 13:06

  Bicara Therapeutics Price Target Maintained With a $31.00/Share by Citizens

• Benzinga·03/31 13:01

  Bicara Therapeutics To Rally Around 121%? Here Are 10 Top Analyst Forecasts For Tuesday